Diazene JK-279 induces apoptosis-like cell death in human cervical carcinoma cells

Toxicology in Vitro

Volumn 20, Issue 2, 2006, Pages 217-226

  Jakopec, S ^a   Dubravcic, K ^b   Polanc, S ^c   Kosmrlj, J ^c   Osmak, M ^a  

^a RUDER BO KOVI INSTITUTE   (Croatia)

^b KBC Zagreb   (Croatia)

^c UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Anti cancer drugs; Apoptosis like cell death; Caspase independent cell death; Diazenes; Tumor cells

Indexed keywords

AMIDE; DNA; JK 279; N PHENYL 2 (2 PYRIDINYL)DIAZENECARBOXAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROCASPASE 3; PROCASPASE 9; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P21; SURVIVIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE REGULATION; CELL DEATH; CELL STRUCTURE; CONTROLLED STUDY; CYTOTOXICITY; DNA CLEAVAGE; DRUG MECHANISM; FLOW CYTOMETRY; HELA CELL; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; UTERINE CERVIX CARCINOMA;

ANNEXIN A5; ANTINEOPLASTIC AGENTS; APOPTOSIS; AZA COMPOUNDS; CASPASE 3; CASPASE 9; CASPASES; CELL CYCLE; CELL DEATH; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; CELL NUCLEUS; CELL SURVIVAL; COLLAGEN TYPE XI; GLUTATHIONE; HELA CELLS; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; PROPIDIUM; PROTO-ONCOGENE PROTEINS P21(RAS); PYRIDINES;

EID: 30644470799     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2005.06.008     Document Type: Article

References (50)

1. G.P. Amarante-Mendes, D.M. Finucane, S.J. Martin, T.G. Cotter, G.S. Salvesen, and D.R. Green Anti-apoptotic oncogenes prevent caspase-dependent and -independent commitment for cell death Cell Death and Differentiation 5 1998 298 306
2. B.A. Arrick, and C.F. Nathan Glutathione metabolism as a determinant of therapeutic efficacy Cancer Research 44 1984 4224 4232
3. F.M. Ausubel, R. Brent, R.E. Kingston, D.D. Moore, J.G. Seidman, J.A. Smith, and K. Struhl Short Protocols in Molecular Biology second ed. 1992 Green Publishing Associates and John Wiley & Sons New York pp. 2-4
4. + T cells Proceedings of the National Academy of Sciences of the USA 95 1998 12556 12561
5. W.S. Choi, E.H. Lee, C.W. Chung, Y.K. Jung, B.K. Jin, S.U. Kim, T.H. Oh, T.C. Saido, and Y.J. Oh Cleavage of Bax is mediated by caspase-dependent or -independent calpain activation in dopaminergic neuronal cells: protective role of Bcl-2 Journal of Neurochemistry 77 2001 1531 1541
6. B. Del Bello, M.A. Valentini, P. Mangiavacchi, M. Comporti, and E. Maellaro Role of caspases-3 and -7 in Apaf-1 proteolytic cleavage and degradation events during cisplatin-induced apoptosis in melanoma cells Experimental Cell Research 293 2004 302 310
7. D.A. Dickinson, and H.J. Forman Cellular glutathione and thiols metabolism Biochemical Pharmacology 64 2002 1019 1026
8. M. Donovan, and T.G. Cotter Control of mitochondrial integrity by Bcl-2 family members and caspase-independent cell death Biochimica et Biophysica Acta 1644 2004 133 147
9. P.J. Duriez, and G.M. Shah Cleavage of poly(ADP-ribose) polymerase: a sensitive parameter to study cell death Biochemistry and Cell Biology 75 1997 337 349
10. W.C. Earnshaw, L.M. Martins, and S.H. Kaufmann Mammalian caspases: structure, activation, substrates, and functions during apoptosis Annual Review of Biochemistry 68 1999 383 424
11. G. Filomeni, G. Rotilio, and M.R. Ciriolo Cell signalling and the glutathione redox system Biochemical Pharmacology 64 2002 1057 1064
12. G. Häcker The morphology of apoptosis Cell and Tissue Research 301 2000 5 17
13. T.C. Hamilton, M.A. Winker, K.G. Loui, G. Batist, B.C. Behrens, T. Tsuruo, K.R. Grotzinger, N.M. McKoy, R.C. Young, and R.F. Ozols Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletion Biochemical Pharmacology 34 1985 2583 2586
14. M.B. Hampton, B. Zhivotovsky, S.F.G. Slater, D.H. Brugess, and S. Orrenius Importance of the redox state of cytochrome C during caspase activation in cytosolic extracts The Biochemical Journal 329 1998 95 99
15. Y.A. Hannum Apoptosis and dilemma of cancer chemotherapy Blood 89 1997 1845 1853
16. U.A. Hirt, F. Gantner, and M. Leist Phagocytosis of nonapoptotic cells dying by caspase-independent mechanisms Journal of Immunology 164 2000 6520 6529
17. S.H. Kaufmann, and W.C. Earnshaw Minireview Induction of apoptosis by cancer chemotherapy Experimental Cell Research 256 2000 42 49
18. J.F. Kerr, A.H. Wyllie, and A.R. Currie Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics British Journal of Cancer 26 1972 239 257
19. J. Kosmrlj, M. Kocevar, and S. Polanc A mild approach to 1,3,4-oxidiazoles and fused 1,2,4-triazoles. Diazenes as intermediates? Synlett 1996 652 654
20. J. Kosmrlj, M. Kocevar, and S. Polanc Controlled oxidation of thiols to disulfides by diazenecarboxamides Journal of the Chemical Society Perkin Transactions 1 1998 3917 3919
21. M. Leist, and M. Jäättelä Four deaths and the funeral: from caspases to alternative mechanisms Nature Reviews Molecular and Cellular Biology 2 2001 589 598
22. Y. Lily, X. Luo, and X. Wang Endonuclease G is an apoptotic DNase when released from mitochondria Nature 412 2001 95 99
23. K.I. Lin, S.H. Lee, R. Narayanan, J.M. Baraban, J.M. Hardwick, and R.R. Ratan Thiol agents and bcl-2 identify an alpha virus-induced apoptotic pathway that requires activation of the transcription factor NF-kappa B The Journal of Cell Biology 131 1995 1149 1161
24. R. Locigno, and V. Castronovo Reduced glutathione system: role in cancer development, prevention and treatment (Review) International Journal of Oncology 19 2001 221 236
25. D.H. Lowry, N.J. Rosenbrough, A.L. Farr, and R.J. Randall Protein measurement with the folin phenol reagent The Journal of Biological Chemistry 193 1951 265 275
26. N.A. Maianski, D. Roos, and T.W. Kuijpers Tumor necrosis factor alpha induces a caspase-independent death pathway in human neutrophils Blood 101 2003 1987 1995
27. I.S. Mathiasen, and M. Jäättelä Triggering caspase-independent cell death to combat cancer Trends in Molecular Medicine 8 2002 212 220
28. G. Mickisch, S. Fajta, G. Keilhauer, E. Schilke, P. Tschada, and P. Alken Chemosensitivity testing of primary human renal cell carcinoma by tetrazolium based microculture assay (MTT) Urological Research 18 1990 131 136
29. T. Miyashita, S. Krajewski, M. Krajewska, H.G. Wang, H.K. Lin, D.A. Liebermann, B. Hoffman, and J.C. Reed Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo Oncogene 9 1994 1799 1805
30. Cip1/Waf1 at both the G1/S and G2/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and preventing endoreduplication Molecular and Cellular Biology 18 1998 629 643
31. D.S. O'Connors, N.R. Wall, A.C. Porter, and D.C. Altieri A p34(cdc2) survival checkpoint in cancer Cancer Cell 2 2002 43 54
32. S. Okuno, S. Shimizu, T. Ito, M. Nomura, E. Hamada, Y. Tsujimoto, and H. Matsuda Bcl-2 prevents caspase-independent cell death The Journal of Biological Chemistry 273 1998 34272 34277
33. M. Osmak, T. Bordukalo, B. Jernej, J. Kosmrlj, and S. Polanc Diazene JK-279 potential anticancer drug Anti-Cancer Drugs 10 1999 853 859
34. M. Osmak, T. Bordukalo, J. Kosmrlj, M. Kvajo, Z. Marijanovic, D. Eljuga, and S. Polanc Diazenes: modificators of tumor cell resistance to cisplatin Neoplasma 46 1999 201 206
35. P. Pognonec, H. Kato, and R.G. Roeder The helix-loop-helix/leucine repeat transcription factor USF can be functionally regulated in a redox dependent manner The Journal of Biological Chemistry 267 1992 24563 24567
36. T. Sandstrom, M.D. Mannie, and T.M. Buttke Inhibition of activation-induced death in T cell hybridomas by thiol antioxidants: oxidative stress as a modulator of apoptosis Journal of Leukocyte Biology 55 1994 221 226
37. H. Schulze-Bergkamen, and P.H. Krammer Apoptosis in cancer-implications for therapy Seminars in Oncology 31 2004 90 119
38. R.E. Shackelford, W.K. Kaufmann, and R.S. Paules Cell cycle control, checkpoint mechanisms, and genotoxic stress Environmental Health Perspectives 107 1999 5 24
39. S.L. Shankar, S. Mani, K.M. O'Guin, E.R. Kandimall, S. Agrawal, and B. Shafit-Zagardo Survivin inhibition induces human neural tumor cell death through caspase-independent and -dependent pathways Journal of Neurochemistry 79 2001 426 436
40. A.F.G. Slater, C. Stefan, I. Nobel, D.J. Van den Dobbelsteen, and S. Orrenius Intracellular redox changes during apoptosis Cell Death and Differentiation 3 1996 57 62
41. A. Suzuki, Y. Tsutomi, K. Akahane, T. Araki, and M. Miura Resistance to Fas-mediated apoptosis: activation of caspase 3 is regulated by cell cycle regulator p21WAF1 and IAP gene family ILP Oncogene 17 1998 931 939
42. A. Suzuki, Y. Tsutomi, M. Miura, and K. Akahane Caspase 3 inactivation to supress Fas-mediated apoptosis: identification of binding domain with p21 and ILP and inactivation machinery by p21 Oncogene 18 1999 1239 1244
43. I. Tamm, Y. Wang, E. Sausville, D.A. Scudiero, N. Vigna, T. Oltersdorf, and J.C. Reed IAP-family protein Survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs Cancer Research 58 1998 5315 5320
44. W.R. Taylor, and G.R. Stark Regulation of the G2/M transition by p53 Oncogene 20 2001 1803 1815
45. A. Temme, M. Rieger, F. Reber, D. Lindemann, B. Weigle, P. Diestelkoetter-Bachert, G. Ehninger, M. Tatsuka, Y. Terada, and E.P. Rieber Localisation, dynamics, and function of survivin revealed by expression of functional SurvivinDsRed fusion proteins in the living cell Molecular Biology of the Cell 14 2003 78 92
46. Y. Tsujimoto Cell death regulation by the Bcl-2 protein family in the mitochondria Journal of Cellular Physiology 195 2003 158 167
47. S. Ussat, U.E. Werner, M.S. Kruse, S. Lüschen, G. Scherer, D. Kabelitz, and S. Adam-Klages Upregulation of p21 (WAF1/Cip1) precedes tumor necrosis factor-induced necrosis-like cell death Biochemical and Biophysical Research Communications 294 2002 672 679
48. A.M. Verhagen, E.J. Coulson, and D.L. Vaux Inhibitor of apoptosis proteins and their relatives: IAP-s and other BIRP-s Genome Biology 2 2001 3009.1 3009.10
49. L. Vukovic, A. Ambriovic-Ristov, T. Cimbora-Zovko, H. Cetkovic, A. Brozovic, D. Majhen, and M. Osmak Expression of apoptotic genes in low, clinically relevant levels of drug resistance Periodicum Biologorum 106 2004 173 177
50. N.R. Wall, D.S. O'Connor, J. Plescia, Y. Pommier, and D.C. Altieri Suppression of survivin phosphorylation on Thr34 by flavopiridol enhances tumor cell apoptosis Cancer Research 63 2003 230 235